查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056569

神經血管醫療設備市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034年

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年全球神經血管醫療設備市場規模為32億美元。展望未來，IMARC Group預測，該市場將以4.74%的複合年成長率從2026年成長至2034年，到2034年達到49億美元。目前，北美市場佔據主導地位，2025年市佔率達27.8%。北美地區的成長得益於先進的醫療基礎設施、創新神經血管器械的普及、神經血管疾病病例的增加以及對研究舉措的大力支持。

中風、動脈瘤和動靜脈畸形等疾病在一般人群中發病率的不斷上升是推動市場成長的主要因素。這些疾病需要精準治療，而現代神經血管醫療設備正是為了應對這些挑戰而設計的，旨在提高病患的存活率和整體生活品質。此外，老年人口的成長也推高了神經血管疾病的高風險，進而推動了針對老年人特定醫療需求的先進治療方案的需求。

此外，微創技術的進步，例如血流導引裝置、血栓除去裝置和栓塞彈簧圈，顯著改善了治療效果。這些裝置因其降低風險、縮短恢復時間並為每位患者提供個人化解決方案，在全球醫療機構中廣泛應用。此外，許多國家完善的保險報銷系統使得昂貴的神經血管治療更容易被病人接受，神經血管裝置的價格也更親民。

美國是一個重要的市場，這主要得益於創新神經血管器械的引入，這些器械旨在提高治療的精確性和安全性。諸如彈簧圈輔助支架等最尖端科技的應用，提高了手術視野和定位精度，顯示人們越來越重視有效治療複雜的神經血管疾病。這些進步凸顯了領先製造商致力於提供滿足臨床需求的創新解決方案的努力。例如，MicroVention公司宣布將於2024年在美國推出其用於治療寬頸腦動脈瘤的LVIS EVO腔內支撐裝置。

這是美國首例全可視化線圈輔助顱內支架，可顯著提高可視性並實現精確定位。此次發布彰顯了MicroVention致力於推動神經血管治療技術的決心。此外，提高大眾對中風預防、快速診斷和治療方案的認知度，也正在加速醫療干預措施的實施。同時，專業發展計畫也正在提升醫護人員的技能，並促進先進技術的應用。

神經血管器械市場的發展趨勢：

技術進步推動創新

神經血管器械領域全球發展的關鍵因素之一是技術的持續創新。醫療設備的進步正在改變神經血管疾病的治療方式，並為各種神經血管疾病提供新的治療選擇。根據健康指標與評估研究所 (IHME) 統計，2021 年，神經系統疾病導致 4.43 億個健康壽命損失，其中包括疾病、殘疾和過早死亡。 3D 列印、先進影像技術和微創手術等最尖端科技正在革新患者照護。

這些進步使得診斷和治療更加精準，從而改善患者預後並降低風險。此外，機器人技術和人工智慧（AI）在神經血管介入治療中的應用顯著改善了手術流程，並提供了個人化的治療方法。持續的研發投入和對技術進步的不懈追求正在推動神經血管器材市場的發展。

神經血管疾病盛行率增加

全球神經血管醫療設備市場的成長趨勢與神經血管疾病盛行率的上升密切相關。據報道，2021年全球有超過30億人患有神經系統疾病。中風、動脈瘤和動靜脈畸形等疾病是全球面臨的健康挑戰。除了人口老化之外，生活方式的改變和風險因素的增加也在推動這些疾病發生率的上升。

隨著病例數量的增加，對高效、先進的神經血管醫療設備的需求日益成長，這些設備對於精準診斷、治療和術後監測至關重要。微創手術因其減輕患者負擔、縮短恢復時間而需求顯著成長。因此，市場正積極響應這一不斷成長的需求，推出創新產品和解決方案，在改善患者治療效果和生活品質方面發揮關鍵作用。

人口老化和微創治療的可近性

人口老化是推動全球神經血管器械市場擴張的重要因素。根據美國人口普查局統計，2020年美國老年人口達5,580萬，占美國總人口的16.8%。隨著老年人罹患神經血管疾病的風險增加，對全面且微創的治療方法的需求也日益成長。老年人通常傾向於選擇微創手術，以減輕身體負擔並縮短恢復時間。因此，製造商正致力於研發針對老年族群的器械，以確保其安全性和有效性。

微創治療方法的日益普及提高了患者的依從性，並滿足了醫療產業對高效經濟治療方案日益成長的需求。老化需求與現有產品之間的關聯性凸顯了神經血管醫療設備產業在滿足不斷變化的醫療保健需求方面發揮的關鍵作用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球神經血管醫療設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 腦栓塞及動脈瘤彈簧圈栓塞裝置
    • 主要部分
      • 栓塞線圈
      • 分流器
      • 液態栓塞劑
  • 腦血管成形術和支架置入系統
    • 主要部分
      • 頸動脈支架
      • 栓塞預防裝置
  • 神經血栓除去裝置
    • 主要部分
      • 血栓除去裝置
      • 吸力裝置
      • 血管勒除器
  • 輔助設備
    • 主要部分
      • 微導管
      • 微導管導引線

第7章 市場區隔：依應用領域分類

  • 缺血性中風
  • 動脈瘤
  • 動靜脈畸形和瘻管（AVM）
  • 收縮
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Acandis GmbH
    • Asahi Intecc Co. Ltd.
    • Imperative Care Inc.
    • Integer Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Penumbra Inc.
    • Perflow Medical Ltd.
    • Rapid Medical
    • Stryker Corporation
    • Terumo Corporation
Product Code: SR112026A6128

The global neurovascular devices market size was valued at USD 3.2 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.9 Billion by 2034, exhibiting a CAGR of 4.74% from 2026-2034. North America currently dominates the market, holding a market share of 27.8% in 2025. The growth of the North American region is driven by advanced healthcare infrastructure, widespread adoption of innovative neurovascular devices, increasing cases of neurovascular disorders, and strong support for research initiatives.

At present, the rising incidence of conditions, such as strokes, aneurysms, and arteriovenous malformations, among the masses represent one of the major factors impelling the market growth. These conditions necessitate exact treatment, which contemporary neurovascular instruments are tailored to tackle, enhancing patient survival rates and overall quality of life. Moreover, the increasing elderly population, which is more prone to neurovascular issues, is driving the demand for enhanced treatment solutions tailored to their unique healthcare requirements.

Additionally, advancements in less invasive technologies, like flow diverters, thrombectomy devices, and embolization coils, are enhancing procedural results. These devices lower risks, shorten recovery durations, and provide customized solutions, promoting extensive use in healthcare settings globally. Furthermore, enhanced reimbursement systems in numerous countries allow patients to obtain expensive neurovascular therapies, rendering neurovascular devices more affordable and accessible.

The United States represents a major market, supported by the introduction of innovative neurovascular devices specifically designed to enhance treatment precision and safety. The presence of cutting-edge technologies, such as coil-assist stents, which enhance visibility and placement precision, indicates an increasing emphasis on effectively treating intricate neurovascular issues. These advancements emphasize the dedication of top manufacturers to providing innovative solutions customized for clinical requirements. For instance, in 2024, MicroVention declared the commercial release of the LVIS EVO Intraluminal Support Device in the United States, intended for the treatment of wide-neck intracranial aneurysms.

It is the initial entirely visible coil-assist intracranial stent in the US, providing improved visualization and accurate positioning. This launch underscores MicroVention's commitment to advancing neurovascular treatment technologies. Furthermore, the growing number of awareness programs about stroke prevention, rapid diagnosis, and treatment choices is leading to quicker medical intervention. Professional development programs are also enhancing the abilities of healthcare workers, encouraging the use of sophisticated technology.

Neurovascular Devices Market Trends:

Technological advancements driving innovation

In the field of global neurovascular devices, a vital factor is the ongoing rise in technological innovations. Advancements in medical devices have transformed neurovascular procedures, offering novel treatment options for a range of neurovascular problems. The Institute for Health Metrics and Evaluation reports that neurological disorders accounted for 443 million years of healthy life lost from illness, disability, and early death in 2021. Cutting-edge technologies such as 3D printing, advanced imaging techniques, and minimally invasive approaches are revolutionizing patient care.

These developments enable more precise diagnosis and treatment, enhancing patient outcomes and reducing risks. Moreover, the integration of robotics and artificial intelligence (AI) in neurovascular interventions is greatly improving procedures and offering personalized therapies. With ongoing research and development (R&D), the relentless pursuit of technological progress drives the neurovascular devices market.

Rising prevalence of neurovascular disorders

The upward trajectory of the global neurovascular devices market is intrinsically linked to the rising prevalence of neurovascular disorders. Reports indicate that in 2021, over 3 billion individuals around the globe were affected by a neurological disorder. Health challenges on a global scale are significantly posed by conditions like strokes, aneurysms, and arteriovenous malformations. The elderly population, along with shifting lifestyles and risk elements, has led to an increased occurrence of these conditions.

This increase in cases requires the creation of efficient and modern neurovascular instruments for precise diagnosis, therapy, and monitoring after treatment. The demand for minimally invasive procedures has notably increased because of their lowered patient discomfort and faster recovery periods. As a result, the market addresses this increasing demand with creative products and solutions, reinforcing its role as a crucial factor in enhancing patient results and overall quality of life.

Geriatric population and accessibility to minimally invasive treatments

The geriatric demographic stands as a significant driver in the expansion of the global neurovascular devices market. According to the Census Bureau, in 2020, the senior population reached 55.8 million, representing 16.8% of the overall US populace. With the growing susceptibility of the elderly population to neurovascular diseases, the demand for comprehensive and minimally invasive treatment options increases. Older individuals usually prefer minimally invasive procedures that lessen physical stress and recovery time. As a result, producers focus on developing devices tailored for this patient group, ensuring their safety and efficiency.

The availability of minimally invasive treatments improves patient compliance and addresses the ongoing emphasis in the healthcare industry on effective and economical options. The link between the needs of the aging population and the market's available products highlights the crucial role of the neurovascular devices sector in meeting evolving healthcare demands.

Neurovascular Devices Industry Segmentation:

The research provides an analysis of the key trends in each segment of the global neurovascular devices market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on product, application, and end user.

Analysis by Product:

  • Cerebral Embolization and Aneurysm Coiling Devices
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolic Agents
  • Cerebral Angioplasty and Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Neurothrombectomy Devices
  • Clot Retrieval Devices
  • Suction Devices
  • Vascular Snares
  • Support Devices
  • Micro Catheters
  • Micro Guidewires

Cerebral and aneurysm coiling devices (embolic coils, flow diverters, and liquid embolic agents) lead the market with 37.8% of market share in 2025. Cerebral embolization and aneurysm coiling devices dominate the market due to their demonstrated efficacy in treating critical conditions like aneurysms and arteriovenous malformations. Such devices, like embolic coils, flow diverters, and liquid embolic agents, provide less invasive treatment alternatives that greatly decrease recovery durations and procedural hazards. Their accuracy in detecting aneurysms and averting rupture has rendered them essential in neurovascular procedures.

Ongoing technological progress has improved their effectiveness, allowing customized solutions for various patient requirements. These devices are commonly used in modern healthcare centers, bolstered by the increasing recognition of their advantages among healthcare practitioners. Cerebral embolization and aneurysm coiling devices have become essential in this market segment due to their vital role in tackling the rising incidence of neurovascular disorders, fostering innovation and enhancing patient outcomes.

Analysis by Application:

  • Ischemic Stroke
  • Aneurysm
  • Arteriovenous Malformation and Fistulas (AVM)
  • Stenosis
  • Others

Ischemic stroke is a significant segment in the market, driven by the rising global incidence of strokes. These instruments, such as thrombectomy devices and stents, are essential in restoring blood circulation and reducing brain injury during crises. The rise in their adoption is driven by progress in less invasive techniques and a heightened focus on early intervention, leading to better patient results.

Aneurysm is a significant issue, as untreated cerebral aneurysms can lead to death. Devices like embolic coils and flow diverters play a vital role in isolating aneurysms, preventing rupture, and reducing complications. Continuous improvements in device design and a rising application in advanced medical settings are enhancing this segment's importance in successfully addressing complex neurovascular challenges.

Arteriovenous malformation and fistulas (AVM) benefits from specialized neurovascular devices that safely and efficiently manage abnormal blood vessel connections. Liquid embolics and other embolization devices are widely used to reduce bleeding risks and enhance treatment success rates. Increasing awareness about AVM conditions and advancements in imaging technologies further drive the adoption of these devices.

Stenosis is vital segment in the market driven by the increasing demand for treatments for constricted blood vessels in the brain. Stenting systems and balloon angioplasty tools are essential for restoring adequate blood circulation, lowering the likelihood of stroke, and enhancing long-term vascular wellness. The segment is experiencing expansion because of the rising occurrence of atherosclerosis and associated ailments.

Others encompass various neurovascular conditions requiring specialized interventions. This category includes devices designed for rare or complex disorders, such as dural fistulas or Moyamoya disease. The ongoing development of targeted solutions and the expansion of clinical applications highlight the importance of this segment in addressing diverse patient needs.

Analysis by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Hospitals lead the market, holding a 70.9% share in 2025. Hospitals hold the largest market share attributed to their advanced infrastructure and ability to handle complex neurovascular procedures. They offer access to multidisciplinary teams of specialists, ensuring comprehensive care for patients with stroke, aneurysms, and other neurovascular disorders. The availability of state-of-the-art equipment and facilities for diagnosis and minimally invasive treatments enhances the success rate of procedures performed in hospitals.

High patient inflow, combined with round-the-clock emergency services, positions hospitals as the primary choice for neurovascular treatments. Their emphasis on clinical training and adoption of innovative technologies ensures the integration of the latest devices and techniques into practice. Hospitals' capability to effectively handle both acute and chronic neurovascular cases makes them crucial in promoting the use of neurovascular devices.

Regional Analysis:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

In 2025, North America held the biggest market share at 27.8%. North America leads the market because of its sophisticated healthcare infrastructure and the extensive access to state-of-the-art medical technologies. The area enjoys a significant number of well-equipped medical centers and a vast array of proficient healthcare experts specializing in neurovascular procedures. Continual research and development efforts, backed by strong government and private sector investment, have hastened the launch of innovative devices designed for intricate neurological disorders. The increasing recognition of neurovascular conditions and the significance of prompt treatment further propel the uptake of these devices.

Moreover, North America possesses a robust regulatory system that promotes prompt product approvals, guaranteeing the accessibility of safe and efficient treatment alternatives. The presence of key market players in the region enhances accessibility to a wide range of neurovascular devices, fostering continuous advancements. In 2024, Cerenovus, part of Johnson & Johnson MedTech, launched the Cereglide 71 catheter for acute ischemic stroke revascularization in the U.S. Featuring TruCourse technology, it offers improved navigation, trackability, and compatibility for thrombectomy procedures. This innovation enhances Cerenovus' Stroke Solutions portfolio, addressing critical clinical needs in stroke care.

Key Regional Takeaways:

United States Neurovascular Devices Market Analysis

The United States represented 70.10% of the overall market share in North America. The market for neurovascular devices in the United States is presently propelled by innovations in minimally invasive surgical methods, allowing quicker recovery periods and fewer complications for patients receiving care for neurovascular issues. Firms are proactively putting resources into creating advanced devices, like stent retrievers and flow diverters, which are showing enhanced effectiveness in treating ischemic and hemorrhagic strokes. The market is also experiencing a rise in the use of AI-driven imaging technologies and robotic-assisted treatments, which are improving accuracy and clinical results in neurovascular procedures.

Increasing awareness initiatives are informing healthcare professionals and patients about the early detection and management of neurovascular conditions, thus broadening the base of patients pursuing these advanced options. Hospitals and surgical facilities are emphasizing the integration of advanced neurovascular device technologies to enhance procedural efficiency and meet the increasing patient demand. Moreover, insurance companies are increasing coverage for cutting-edge procedures, thus making advanced neurovascular treatments more available to a wider audience. According to the U.S.

Department of Agriculture (USDA), the United States population hit 334,914,895 in 2023. The FDA is promoting a competitive environment that stimulates innovation by expediting the authorization and approval of novel neurovascular devices. Medical facilities are also improving their training programs for physicians to improve their proficiency with these complex gadgets, which will expand their market reach.

Europe Neurovascular Devices Market Analysis

The market for neurovascular devices in Europe is presently expanding due to a combination of factors. The area is experiencing a rise in the use of sophisticated minimally invasive techniques for addressing neurovascular conditions like aneurysms, ischemic strokes, and arteriovenous malformations, as medical professionals aim to shorten recovery periods and enhance patient results. Governments and private entities are vigorously financing research and clinical studies for cutting-edge devices such as flow diverters and embolization coils, which is hastening product development and market introduction.

At the same time, the increasing elderly population in Europe is leading to a higher incidence of neurovascular diseases, encouraging healthcare systems to enhance their neurointerventional services. As reported by Eurostat, in 2019, there were 90.4 million elderly individuals (aged 65 and above) residing in the EU-27. Hospitals and specialized clinics are consistently enhancing their equipment collections to feature advanced imaging and navigation technologies that support neurovascular devices, improving procedural precision. Moreover, European regulatory authorities are simplifying approval procedures for novel neurovascular devices, promoting quicker market entry of innovative solutions.

As emphasis on international collaborations increases, manufacturers are establishing strategic alliances with research institutes and hospitals, promoting innovation that meets local requirements. Additionally, the growing accessibility of training programs for neurointerventional specialists is enhancing procedural skills, facilitating the use of neurovascular devices in everyday clinical practice throughout Europe.

Asia Pacific Neurovascular Devices Market Analysis

The neurovascular devices market in the Asia-Pacific region is presently experiencing growth fueled by various localized factors. Improvements in healthcare systems in developing nations such as India and Indonesia are facilitating improved access to neurovascular treatments, bolstered by government efforts to increase the accessibility of sophisticated medical equipment. The area is experiencing a rise in neurovascular disorders like strokes and aneurysms, linked to lifestyle changes, an aging population, and a higher occurrence of hypertension and diabetes. As per the IDF Diabetes Atlas, the number of individuals impacted by diabetes (in thousands) in China in 2021 is 140,869.6.

Healthcare providers are progressively embracing minimally invasive techniques because of their reduced risk factors and quicker recovery periods, driving the need for sophisticated neurovascular tools such as embolic coils and flow diverters. Top manufacturers are partnering with local distributors and establishing strategic alliances to broaden their presence, particularly in markets such as China and Japan, where rapid adoption of advanced devices is driven by an increasing emphasis on state-of-the-art medical technologies.

At the same time, the growth of medical tourism in nations like Thailand and Malaysia is enhancing access to cost-effective and high-quality neurovascular treatments, drawing in patients from around the world. Regulatory authorities in the area are simplifying approval procedures, enabling quicker market access for advanced neurovascular products, thus fostering innovation and rivalry in the Asia-Pacific market.

Latin America Neurovascular Devices Market Analysis

The neurovascular devices market in Latin America is supported by the growing acceptance of minimally invasive surgical methods and increased awareness among patients and healthcare providers about their benefits, including quicker recovery times and lower complication risks. Hospitals and specialized clinics are upgrading their infrastructure and resources, focusing on equipping facilities with advanced neurovascular equipment to meet the increasing demand for stroke care and other neurovascular disorders. The region is seeing a rise in healthcare investment, especially in countries like Brazil and Mexico, where officials are concentrating on enhancing neurology services through collaborations between public and private sectors.

Additionally, companies are actively launching creative products tailored to the specific needs of Latin American communities, addressing issues such as affordability and accessibility. The growing prevalence of lifestyle-associated risk factors, such as hypertension and diabetes, is contributing to a greater number of strokes, consequently increasing reliance on advanced technologies for clot removal and aneurysm management.

As per the IDF Diabetes Atlas, the diabetes prevalence in Mexico was approximately 17% in 2021. At the same time, healthcare professionals regularly participate in specialized training sessions provided by device manufacturers to guarantee the effective use of these technologies. Community programs that encourage early detection and treatment offer extra assistance to the market, leading to improved patient results.

Middle East and Africa Neurovascular Devices Market Analysis

The neurovascular device market in the Middle East and Africa is growing due to multiple region-specific factors. To address the growing prevalence of neurovascular diseases including aneurysms and strokes, governments and commercial healthcare organizations are now investing more in healthcare infrastructure, especially in institutions devoted to neurology. Medical tourism is expanding in countries like the UAE and South Africa, supported by advanced neurological treatment facilities that are encouraging the utilization of minimally invasive neurovascular devices. According to the Ministry of Economy, the medical tourism industry in the UAE generated AED 12.1 Billion (USD 3.29 Billion) in 2018.

Concurrently, regional healthcare entities are strengthening partnerships with international producers to launch advanced technological devices in the market, addressing the unmet needs in stroke management and interventional neurology. Furthermore, the rising prevalence of hypertension, diabetes, and sedentary habits is elevating the demand for new approaches to tackle associated neurovascular problems.

Training sessions and workshops are being conducted more frequently to improve the abilities of healthcare professionals in using advanced equipment, thereby guaranteeing improved patient results. Governments are swiftly accelerating regulatory clearances and endorsing clinical trials in this field, enhancing access to groundbreaking neurovascular products. These elements are jointly establishing a conducive atmosphere for the continuous expansion of the neurovascular devices market in the region.

Competitive Landscape:

Key players in the market are focusing on expanding their product portfolios through innovative solutions and advanced technologies to address complex neurovascular conditions. They are heavily investing in research operations to enhance device efficiency, safety, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are being pursued to strengthen market presence and gain access to emerging regions. These companies are also prioritizing regulatory approvals to ensure global availability and compliance with healthcare standards. Additionally, they are leveraging advanced manufacturing techniques to reduce production costs while maintaining quality.

In 2024, Philips and Medtronic Neurovascular announced a joint advocacy initiative designed to enhance global access to essential stroke therapies. The collaboration seeks to raise awareness, improve access to treatments, and implement advanced technologies for effective stroke care management. The two firms joined the World Stroke Organization Advocacy Coalition to advocate for global stroke care policies.

The report provides a comprehensive analysis of the competitive landscape in the neurovascular devices market with detailed profiles of all major companies, including:

  • Acandis GmbH
  • Asahi Intecc Co. Ltd.
  • Imperative Care Inc.
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Perflow Medical Ltd.
  • Rapid Medical
  • Stryker Corporation
  • Terumo Corporatio.

Key Questions Answered in This Report

  • What are neurovascular devices?
  • How big is the neurovascular devices market?
  • What is the expected growth rate of the global neurovascular devices market during 2026-2034?
  • What are the key factors driving the global neurovascular devices market?
  • What is the leading segment of the global neurovascular devices market based on product?
  • What is the leading segment of the global neurovascular devices market based on end user?
  • What are the key regions in the global neurovascular devices market?
  • Who are the key players/companies in the global neurovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cerebral Embolization and Aneurysm Coiling Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Embolic Coils
      • 6.1.2.2 Flow Diverters
      • 6.1.2.3 Liquid Embolic Agents
    • 6.1.3 Market Forecast
  • 6.2 Cerebral Angioplasty and Stenting Systems
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Carotid Artery Stents
      • 6.2.2.2 Embolic Protection Devices
    • 6.2.3 Market Forecast
  • 6.3 Neurothrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Clot Retrieval Devices
      • 6.3.2.2 Suction Devices
      • 6.3.2.3 Vascular Snares
    • 6.3.3 Market Forecast
  • 6.4 Support Devices
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Micro Catheters
      • 6.4.2.2 Micro Guidewires
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aneurysm
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Arteriovenous Malformation and Fistulas (AVM)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Stenosis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acandis GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Asahi Intecc Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Imperative Care Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Integer Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Johnson & Johnson
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MicroPort Scientific Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Penumbra Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perflow Medical Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rapid Medical
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurovascular Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Neurovascular Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Neurovascular Devices Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Neurovascular Devices Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Neurovascular Devices Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Neurovascular Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Neurovascular Devices (Neurothrombectomy Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Neurovascular Devices (Neurothrombectomy Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Neurovascular Devices (Support Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Neurovascular Devices (Support Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Neurovascular Devices (Ischemic Stroke) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Neurovascular Devices (Ischemic Stroke) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Neurovascular Devices (Aneurysm) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Neurovascular Devices (Aneurysm) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Neurovascular Devices (Stenosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Neurovascular Devices (Stenosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Neurovascular Devices (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Neurovascular Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Neurovascular Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Neurovascular Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Neurovascular Devices (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Neurovascular Devices (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Neurovascular Devices (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Neurovascular Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: North America: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: North America: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: United States: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: United States: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Canada: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Canada: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Asia-Pacific: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Asia-Pacific: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: China: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: China: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Japan: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Japan: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: India: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: India: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: South Korea: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: South Korea: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Australia: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Australia: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Indonesia: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Indonesia: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Others: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Others: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Europe: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Europe: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Germany: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Germany: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: France: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: France: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: United Kingdom: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: United Kingdom: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Italy: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Italy: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Spain: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Spain: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Russia: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Russia: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Latin America: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Latin America: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Brazil: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Brazil: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Mexico: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Mexico: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Others: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Others: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Middle East and Africa: Neurovascular Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Middle East and Africa: Neurovascular Devices Market: Breakup by Country (in %), 2025
  • Figure 82: Middle East and Africa: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Global: Neurovascular Devices Industry: SWOT Analysis
  • Figure 84: Global: Neurovascular Devices Industry: Value Chain Analysis
  • Figure 85: Global: Neurovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurovascular Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Neurovascular Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Neurovascular Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Neurovascular Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Neurovascular Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Neurovascular Devices Market: Competitive Structure
  • Table 7: Global: Neurovascular Devices Market: Key Players